000 01119 a2200349 4500
005 20250512093338.0
264 0 _c19700701
008 197007s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(70)91210-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHunter, K R
245 0 0 _aAmantadine in parkinsonism.
_h[electronic resource]
260 _bLancet (London, England)
_cMay 1970
300 _a1127-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAmantadine
_xadverse effects
650 0 4 _aChlorides
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aPlacebos
700 1 _aStern, G M
700 1 _aLaurence, D R
700 1 _aArmitage, P
773 0 _tLancet (London, England)
_gvol. 1
_gno. 7657
_gp. 1127-9
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(70)91210-9
_zAvailable from publisher's website
999 _c4197467
_d4197467